Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Season 2 of the “Love in Gravity” podcast, presented by ViiV Healthcare, features football, faith, HIV, Latina moms and more.
The USPSTF’s latest recommendation could make long-acting PrEP (Apretude) more accessible—if a looming court case doesn’t interfere.
The 38th annual AIDS Walk New York supports GMHC and other HIV and AIDS groups. Plus: Don’t miss the Latex Ball!
This NWGHAAD, learn what all women need to know about HIV, including who is impacted most. Plus: Download self-care activity books.
The U.S. Business Action to End HIV coalition boosts public-private partnerships and spells out six ways companies can fight the epidemic.
The ViiV Healthcare grants are a key element of the company’s Risk to Reason HIV initiative guided by and for Black women.
Held in Puerto Rico, #2022USCHA highlighted HIV in Latino populations, language justice, storytelling, music and much more.
Gilead, ViiV, NMAC, HRC, NBJC, GLAAD and others offer $5.5 million in grants to help community groups respond to monkeypox.
Generic cabotegravir, an every-other-month injectable to prevent HIV, will arrive in select countries. WHO and Health Gap have opinions.
Cultural influencers take off their blindfolds to destigmatize HIV prevention in ViiV’s “Me in You, You in Me” campaign. [VIDEOS]
ViiV Healthcare’s Risk to Reasons initiative offers stigma-free language for discussing HIV and Black women. Apply now for grants.
The Women as the Face of AIDS Summit, organized by Iris House, also honored three trailblazing women working to end the HIV epidemic.
The approval makes this the first single-pill regimen containing dolutegravir available in a water-dispersible formulation.
Using the new dosing schedule, injectable cabotegravir and rilpivirine can be administered just six times a year.
Injectable cabotegravir and rilpivirine are approved for people with viral suppression who would prefer monthly injections to daily pills.
A study analyzed how well people with HIV and their health care providers can navigate the experimental long-acting injectable Cabenuva.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.